학술논문
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
Document Type
Artikel
Author
Source
Blood. 141(14):1675-1684
Subject
Language
English
English
English
ISSN
1528-0020